21216 ⎘
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen; Proteins Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Peptide and conjugate vaccines for fungal infections
#602Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
#603Enolase peptide conjugate vaccines against
#604Immunogenic compositions of antigens
#605Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
#606Conjugation process
#607Conjugated β-1,3-linked glucans
#608Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with
#609Conjugation of streptococcal capsular saccharides
#610Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-1 GP120 3074 mAb epitope and scaffold proteins containing said peptide
#611Combination heptavalent vaccine
#612Methods of making hemagglutinin proteins
#613Method for stabilization of biological molecules
#614Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines
#615OMV vaccines
#616Conjugates comprising an antigen and a carrier molecule
#617Cholera toxin chimera and its use as a staph vaccine
#618Methods of treatment with compositions that include hemagglutinin
#619Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
#620THERAPEUTIC IMMUNIZATION IN HIV INFECTED SUBJECTS TO AUGMENT ANTIRETROVIRAL TREATMENT
#621Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules
#622Peptides, conjugates and method for increasing immunogenicity of a vaccine
#623Peptides mimicking HIV-1 viral epitopes in the V2 loop for the GP120 surface envelope glycoprotein
#624Immunogenic compositions against human progastrin peptides
#625Chloroplasts engineered to express pharmaceutical proteins
#626Prevention And Treatment Of Amyloidogenic Disease
#627(POLY)-GLYCEROLPHOSPHATE-BASED ANTI-GRAM POSITIVE BACTERIAL VACCINE
#628Formulations which stabilize and inhibit precipitation of immunogenic compositions
#629Mutant CTAI fusion protein for treatment of allergy and autoimmune disease
#630ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM
#631HUMAN CHORIONIC GONADOTROPIN (hCG) BASED VACCINE FOR PREVENTION AND TREATMENT OF CANCER
#632Nucleic acids encoding GAS57 mutant antigens
#633Process for manufacturing vaccines
#634Globo H and related anti-cancer vaccines with novel glycolipid adjuvants
#635Immunogenic LHRH compositions and methods relating thereto
#636COMPOSITIONS AND USES
#637COMPOSITIONS AND USES
#638Conjugation process of bacterial polysaccharides to carrier proteins
#639IMMUNOGENIC COMPOSITION COMPRISING S. PNEUMONIAE POLYSACCHARIDES CONJUGATED TO CARRIER PROTEINS
#64015-VALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE VACCINE COMPOSITION
#641Targeting poly-gama-glutamic acid to treat and related infections
#642lipopolysaccharide outer core epitope
#643Purification of type 5 capsular saccharides
#644Compositions and methods for activating innate and allergic immunity
#645Compositions and methods for preparing serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
#646Prevention and Treatment of Amyloidogenic Disease
#647Methods and compositions for mycoplasma pneumoniae exotoxins
#648Vaccine
#649Conjugation of type 5 and type 8 capsular polysaccharides
#650Multivalent pneumococcal polysaccharide-protein conjugate composition
#651De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
#652Vectors for molecule delivery to CD11b expressing cells
#653Vaccine composition
#654POLYPEPTIDES AND POLYNUCLEOTIDES FOR ENHANCING IMMUNE REACTIVITY TO HER-2 PROTEIN
#655Multiepitope vaccine for Her2/neu-associated cancers
#656POLYANIONIC POLYMER ADJUVANTS FOR HAEMOPHILUS INFLUENZAE B SACCHARIDE VACCINES
#657METHODS OF IMPROVING VACCINE IMMUNOGENICITY
#658Methods for preparing complex multivalent immunogenic conjugates
#659Vaccine targeting cellular death receptor DR5
#660lipopolysaccharide outer core epitope
#661Methods and compositions for promoting a cell-mediated immune response
#662EXPRESSION OF PROTECTIVE ANTIGENS IN TRANSGENIC CHLOROPLASTS AND THE PRODUCTION OF IMPROVED VACCINES
#663HIV CD4 BINDING SITE BASED COVALENT IMMUNOGEN COMPOSITIONS
#664Compositions comprising angiogenic factors and methods of use thereof
#665Manufacture of vaccines that contain both hepatitis B virus surface antigens and surfactant
#666Immunogenic compositions of antigens
#667IMMUNOGENIC STREPTOCOCCUS PNEUMONIAE PEPTIDES AND PEPTIDE-MULTIMERS
#668Drug transporter, and adjuvant and vaccine each utilizing same
#669Methods and compositions for treating and preventing Shiga toxin-producing infection
#670Polysaccharide-protein conjugate vaccines
#671Recombinant fusion protein and polynucleotide construct for immunotoxin production
#672TARGETED MULTI-EPITOPE DOSAGE FORMS FOR INDUCTION OF AN IMMUNE RESPONSE TO ANTIGENS
#673COMBINATIONS OF MENINGOCOCCAL FACTOR H BINDING PROTEIN AND PNEUMOCOCCAL SACCHARIDE CONJUGATES
#674PNEUMOCOCCAL VACCINE AND USES THEREOF
#675Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof
#676Vaccine
#677Purification method
#678Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction
#679INDUCTION OF MUCOSAL IMMUNE RESPONSES BY MUCOSAL DELIVERY PENTABODY COMPLEX (MDPC)
#680MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH NON-HIB VACCINES
#681Mixing lyophilised meningococcal vaccines with D-T-Pa vaccines
#682Prevention and Treatment of Amyloidogenic Disease
#683Conjugates for the prevention or treatment of nicotine addiction
#684Capsule composition for use as immunogen against
#685IgE CH3 peptide vaccine
#686IMMUNOGENIC LHRH COMPOSITIONS AND METHODS RELATING THERETO
#687PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#688Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof
#689BSA-specific antibodies
#690Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopes
#691Capsular gram-positive bacteria bioconjugate vaccines
#692Polysaccharide conjugation with detoxified heat labile enterotoxin (LT) used as vaccine
#693Probiotics, secretory IgA and inflammation
#694Synthetic peptide constructs for the diagnosis and treatment of Periodontitis associated with
#695METHOD OF INDUCING AN ANTI-VIRAL IMMUNE RESPONSE
#696Pharmaceutical composition using gonadotropin-releasing hormone (GNRH) combined variants as immunogen
#697Bacterial Polysaccharide-Polypeptide Conjugate Compositions
#698LPS Based Vaccines
#699COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING URINARY TRACT INFECTIONS
#700Vaccine
#701HAPTEN-CARRIER CONJUGATES FOR TREATING AND PREVENTING NICOTINE ADDICTION
#702Targeting poly-γ-glutamic acid to treat and related infections
#703Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies
#704Vaccine for shigella
#705Vaccine Composition
#706Vaccine compositions comprising a saponin adjuvant
#707Immunotherapeutic compositions for the treatment of alzheimer'S disease
#708MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION
#70915-valent pneumococcal polysaccharide-protein conjugate vaccine composition
#710PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#711PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#712NOVEL FORMULATIONS WHICH STABILIZE AND INHIBIT PRECIPITATION OF IMMUNOGENIC COMPOSITIONS
#713Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof
#714Tat DNA sequences, gene constructs, vaccine and processes thereof
#715MUCOSAL COMBINATION VACCINES FOR BACTERIAL MENINGITIS
#716Compositions and methods for diagnosing and treating urinary tract infections
#717MUCOSAL MENINGOCOCCAL VACCINES
#718Methods and compositions relating to synthetic β-1,6 glucosamine oligosaccharides
#719Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof
#720Multivalent vaccine composition with mixed carrier
#721GAS57 mutant antigens and GAS57 antibodies
#722Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
#723Multivalent pneumococcal polysaccharide-protein conjugate composition
#724Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
#725PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#726Glucan-based vaccines
#727Type 5 and type 8 capsular polysaccharides of overproducing strains
#728HIV VACCINE FOR MUCOSAL DELIVERY
#729Conjugated beta-1,3-linked glucans
#730Combination of protein vaccine and mesenchymal stem cells for treating cancer
#731PROCESS FOR TREATMENT OF RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS
#732Hapten-carrier conjugates for treating and preventing nicotine addiction
#733PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS, NON-VIRAL BASED CANCERS, ALZHEIMERS'S DISEASE, MUSCULAR DYSTROPHY, ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVITY DISORDER, COMPLEX REGIONAL PAIN SYNDROME, DIABETES, NEUROPATHIC PAIN, SPIDER ARTHRITIS, WEST NILE VIRUS, FIBROMYALGIA, SHINGLES, GOUT, MIGRAINE HEADACHES, SENILE DEMENTIA, POST POLIO SYNDROME, CENTRAL VIRUS DEAFNESS, ASTHMA, CHRONIC PAIN OF UNKNOWN ORIGIN AND HEPATITIS C
#734Anticancer Combination Therapies
#735Immunogenic composition
#736Modified saccharides
#737Multivalent pneumococcal polysaccharide-protein conjugate composition
#738Subunit vaccine for aquaculture
#739Methods of delivery of exogenous proteins to the cytosol and uses thereof
#740RECOMBINANT ADENYLATE CYCLASE TOXIN OF BORDETELLA INDUCES T CELL RESPONSES AGAINST TUMORAL ANTIGENS
#741Conjugation process for PNAG and a carrier protein
#742Meningococcal oligosaccharide linked polysaccharides and diptheria protein conjugate vaccine for all ages
#743Vaccine
#744Methods and compositions for exotoxins
#745VACCINES
#746ADJUVANTED GLUCANS
#747De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
#748Analysis of mixtures including proteins
#749Anti-obese immunogenic hybrid polypeptides and anti-obese vaccine composition comprising the same
#750Vaccine comprising capsular polysaccharide conjugates
#751Method of immunizing humans against using a Vi-EPA conjugate vaccine
#752Conjugate purification
#753Polyanionic polymer adjuvants for B saccharide vaccines
#754Process for manufacturing vaccines
#755Acyl pseudodipeptides which carry a functionalized auxiliary arm
#756Vaccine comprising capsular polysaccharide conjugates
#757HAPTEN-CARRIER CONJUGATES FOR USE IN DRUG-ABUSE THERAPY AND METHODS FOR PREPARATION OF SAME
#758METHOD FOR DELIVERING A HUMAN CHORIONIC GONADOTROPIN (Hcg) VACCINE FOR LONG-ACTING ANTIBODY PROTECTION
#759Vaccines Containing Non-Live Antigenic Vectors
#760Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof
#761Universal carrier for targeting molecules to Gb3 receptor expressing cells
#762Compositions comprising a B subunit of Shiga toxin and a means stimulating NKT cells
#763MODIFIED POLYSACCHARIDES FOR CONJUGATE VACCINES
#764VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES
#765Vaccines against influenza virus
#766Process for manufacturing vaccines
#767protein antigens and methods
#768Globo H and related anti-cancer vaccines with novel glycolipid adjuvants
#769COMBINATION GAS VACCINES AND THERAPEUTICS
#770Combination therapy for the treatment of tumors
#771protein antigens and methods
#772Vaccine
#773Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein
#774Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
#775Meningococcal conjugate vaccination
#776Modification of exosomal components for use as a vaccine
#777Hypo- and Hyper- Acetylated Meningococcal Capsular Saccharides
#778PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS
#779Pneumococcal polysaccharide conjugate vaccine
#780VACCINE
#781POLYSACCHARIDE DERIVATIVES AND USES IN INDUCTION OF AN IMMUNE RESPONSE
#782Hapten-carrier conjugates for use in drug abuse therapy and methods for preparation of same
#783CHOLESTEROL-CONTAINING COMPOUNDS AND THEIR USE AS IMMUNOGENS AGAINST BORRELIA BURGDORFERI
#784Peptide vaccine for inducing the production of anti-amyloid β-peptide antibody
#785Amyloid-beta polypeptide vaccine
#786Methods for preparing immunogenic conjugates
#787Generation of a cancer-specific immune response toward MUC1 and cancer specific MUC1 antibodies
#788IMMUNOGENIC COMPOSITION
#789Method to reduce the physiologic effects of drugs on mammals
#790Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined with Surgery, Chemotherapy or Radiotherapy for the Treatment of Cancer
#791COMPOSITIONS AND METHODS FOR ACTIVATING INNATE AND ALLERGIC IMMUNITY
#792Compositions and methods for activating innate and allergic immunity
#793COMPOSITIONS FOR INDUCING IMMUNE RESPONSES SPECIFIC TO GLOBO H AND SSEA3 AND USES THEREOF IN CANCER TREATMENT
#794VACCINE
#795NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#796Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment
#797PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#798Immunogenic LHRH compositions and methods relating thereto
#799PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#800PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASES
#801Prion epitopes and methods of use thereof
#802HER-2/NEU MULTI-PEPTIDE VACCINE
#803METHOD OF PRODUCING MENINGOCOCCAL MENINGITIS VACCINE FOR NEISSERIA MENINGITIDIS SEROTYPES A, C, Y, and W-135
#804Immunogenic composition
#805MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION
#806Process for stabilizing an adjuvant containing vaccine composition
#807Vaccines against O157 infection
#808Immunogenic LHRH compositions and methods relating thereto
#809Combination vaccines with whole cell pertussis antigen
#810METHODS AND COMPOSITIONS FOR THE PREPARATION AND USE OF TOXIN CONJUGATES
#811VACCINE AGAINST NICOTINE ADDICTION
#812Combination therapy for the treatment of tumors
#813Prevention and treatment of amyloidogenic disease
#814Capsular polysaccharide solubilisation and combination vaccines
#815Capsular polysaccharide solubilisation and combination vaccines
#816Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
#817Capsular polysaccharide solubilisation and combination vaccines
#818Capsular polysaccharide solubilisation and combination vaccines
#819SEPARATION OF CONJUGATED AND UNCONJUGATED COMPONENTS
#820Compositions of influenza viral proteins and methods of use thereof
#821Manufacture of Vaccines That Contain Both Hepatitis B Virus Surface Antigen and Surfactant
#822Methods and Compositions for Inducing an Immune Response Against Multiple Antigens
#823Adhesin-enterotoxin chimera based immunongenic composition against enterotoxigenic
#824Immunogenic composition
#825Adjuvant activities of mutants of LT-IIa and LT-IIb enterotoxin lacking binding to ganglioside
#826Capsular polysaccharide solubilisation and combination vaccines
#827Capsular polysaccharide solubilisation and combination vaccines
#828Multivalent pneumococcal polysaccharide-protein conjugate composition
#829Capsular polysaccharides solubilisation and combination vaccines
#830Composition and method for enhancing immune response
#831Recombinant adenylate cyclase toxin of induces T cell responses against tumoral antigens
#832Nanoparticles comprising antigens and adjuvants, and immunogenic structures
#833Methods for preparing complex multivalent immunogenic conjugates
#834NOVEL METHOD FOR DOWN-REGULATION OF AMYLOID
#835TRANSGENIC PLANT-BASED VACCINES
#836HIV VACCINE FOR MUCOSAL DELIVERY
#837Immunogenic compositions and methods
#838Humanized antibodies that recognize beta amyloid peptide
#839Compositions and methods for diagnosing and treating urinary tract infections
#840Integration of meningococcal conjugate vaccination
#841Compositions and methods for transepithelial molecular transport
#842Use of alpha-toxin for treating and preventing staphylococcus infections
#843Method for improving the immunogenicity of plasmodium antigens
#844Conjugation of streptococcal capsular saccharides
#845Immunogenic composition
#846Intranasal vaccine for use against disease caused by enterotoxigenic
#847Vaccine
#848Cleavable vaccine compositions and uses thereof and methods of making and using the same
#849Vaccine Comprising Streptococcus Pneumoniae Capsular Polysaccharide Conjugates
#850SKIN IMMUNIZATION USING LT-STA FUSION PROTEINS
#851Pneumococcal Polysaccharide Conjugate Vaccine
#852Oligosialic acid derivatives, methods of manufacture, and immunological uses
#853Capsule composition for use as immunogen against
#854Combination treatment of pancreatic cancer
#855METHOD OF PRODUCING MENINGOCOCCAL MENINGITIS VACCINE FOR NEISSERIA MENINGITIDIS SEROTYPES A, C, Y, and W-135
#856Enzymatic degradation of lipid A fatty acids of bacterial LPS
#857Conjugate Vaccines
#858Mutant forms of EtxB and CtxB and their use as carriers
#859HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE
#860Vaccine Compositions Comprising a Saponin Adjuvant
#861Chloroplasts Engineering to Express Pharmaceutical Proteins
#862Oral Vaccines for Fish
#863Saccharide Conjugate Vaccines
#864Combined meningococcal conjugates with common carrier protein
#865Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope
#866Prevention and treatment of amyloidogenic diseases
#867Prevention and treatment of amyloidogenic diseases
#868DNA vaccine
#869Process for the preparation and use of a bivalent vaccine against morphine-heroine addiction
#870Liquid vaccines for multiple meningococcal serogroups
#871PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#872Prevention and treatment of amyloidogenic disease
#873Humanized antibodies that recognize beta amyloid peptide
#874Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections
#875Immunogenic composition
#876Glycosylceramide adjuvant for saccharide antigens
#877Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines
#878Immunogenic composition
#879Use of alpha-toxin for treating and preventing staphylococcus infections
#880Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with
#881Glycoconjugates and their use as potential vaccines against infection by
#882Hybrid Shiga-like toxin
#883PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#884Protein matrix vaccines and methods of making and administering such vaccines
#885VACCINE COMPOSITION
#886Vaccines
#887Method to reduce the physiologic effects of drugs on mammals
#888Humanized antibodies that recognize beta amyloid peptide
#889Method to reduce the physiologic effects of drugs on mammals
#890Hapten-carrier conjugates for treating and preventing nicotine addiction
#891Method of producing meningococcal meningitis vaccine for serotypes A,C,Y, and W-135
#892METHOD OF PRODUCING MENINGOCOCCAL MENINGITIS VACCINE FOR NEISSERIA MENINGITIDIS SERO TYPES A,C,Y, and W-135
#893Antigen mimotopes and vaccine against cancerous diseases
#894Targeting of genetic vaccine vectors
#895Method of protecting against staphylococcal infection
#896Fusion protein of porcine reproductive and respiratory syndrome virus as PRRS vaccine
#897Conjugation of biomolecules using Diels-Alder cycloaddition
#898Vaccines
#899Compositions and Methods for Treating Neurological Diseases
#900NOVEL PROCESSES FOR COATING CONTAINER MEANS WHICH INHIBIT PRECIPITATION OF POLYSACCHARIDE-PROTEIN CONJUGATE FORMULATIONS